Lindemann K - Search Results

1

Real-world data on niraparib maintenance treatment in patients with non-gBRCA mutated platinum-sensitive recurrent ovarian cancer.

Vilming B, Fallås Dahl J, Bentzen AG, Ingebrigtsen VA, Berge Nilsen E, Vistad I, Dørum A, Solheim O, Bjørge L, Zucknick M, Aune G, Lindemann K. Vilming B, et al. Among authors: lindemann k. Int J Gynecol Cancer. 2023 Dec 4;33(12):1898-1905. doi: 10.1136/ijgc-2023-004484. Int J Gynecol Cancer. 2023. PMID: 38000795 Free PMC article.

2

Minimal residual disease in breast cancer and gynecological malignancies: phenotype and clinical relevance.

Roggel F, Hocke S, Lindemann K, Sinz S, Welk A, Bosl M, Pabst M, Nusser N, Braun S, Schmitt M, Harbeck N. Roggel F, et al. Among authors: lindemann k. Recent Results Cancer Res. 2003;162:89-100. doi: 10.1007/978-3-642-59349-9_8. Recent Results Cancer Res. 2003. PMID: 12790324 Review.

3

Administration of the cytoprotectant amifostine.

Lindemann K. Lindemann K. Clin J Oncol Nurs. 1998 Jul;2(3):101-4. Clin J Oncol Nurs. 1998. PMID: 10232150

4

Detection of micrometastatic disease in bone marrow: is it ready for prime time?

Janni W, Rack B, Lindemann K, Harbeck N. Janni W, et al. Among authors: lindemann k. Oncologist. 2005 Aug;10(7):480-92. doi: 10.1634/theoncologist.10-7-480. Oncologist. 2005. PMID: 16079315 Free article. Review.

5

Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist).

Lindemann K, Gibbs E, Åvall-Lundqvist E, dePont Christensen R, Woie K, Kalling M, Auranen A, Grenman S, Hoegberg T, Rosenberg P, Skeie-Jensen T, Hjerpe E, Dørum A, Gebski V, Kristensen G. Lindemann K, et al. Br J Cancer. 2017 Feb 14;116(4):455-463. doi: 10.1038/bjc.2016.435. Epub 2017 Jan 24. Br J Cancer. 2017. PMID: 28118323 Free PMC article. Clinical Trial.

6

Enhanced Recovery After Surgery for Advanced Ovarian Cancer: A Systematic Review of Interventions Trialed.

Lindemann K, Kok PS, Stockler M, Jaaback K, Brand A. Lindemann K, et al. Int J Gynecol Cancer. 2017 Jul;27(6):1274-1282. doi: 10.1097/IGC.0000000000000981. Int J Gynecol Cancer. 2017. PMID: 28498237 Review.

7

Enhanced Recovery After Surgery for Suspected Ovarian Malignancy: A Survey of Perioperative Practice Among Gynecologic Oncologists in Australia and New Zealand to Inform a Clinical Trial.

Lindemann K, Kok PS, Stockler M, Sykes P, Brand A. Lindemann K, et al. Int J Gynecol Cancer. 2017 Jun;27(5):1046-1050. doi: 10.1097/IGC.0000000000000982. Int J Gynecol Cancer. 2017. PMID: 28525497

8

Clinical Outcome of Patients With High-Risk Endometrial Carcinoma After Treatment With Chemotherapy Only.

Smogeli E, Cvancarova M, Wang Y, Davidson B, Kristensen G, Lindemann K. Smogeli E, et al. Among authors: lindemann k. Int J Gynecol Cancer. 2018 Nov;28(9):1789-1795. doi: 10.1097/IGC.0000000000001356. Int J Gynecol Cancer. 2018. PMID: 30365455

9

Preferences for follow up in long-term survivors after cervical cancer.

Vistad I, Lindemann K, Bentzen AG, Dahl AA, Steen R, Kiserud C. Vistad I, et al. Among authors: lindemann k. Acta Obstet Gynecol Scand. 2020 Sep;99(9):1253-1259. doi: 10.1111/aogs.13855. Epub 2020 Apr 15. Acta Obstet Gynecol Scand. 2020. PMID: 32232835 Free article.

10

Use of PROM during follow-up of patients with ovarian cancer: the PROMova study protocol.

Kargo AS, Coulter A, Lindemann K, Jensen PT, Hjøllund NH, Mosgaard BJ, Steffensen KD. Kargo AS, et al. Among authors: lindemann k. Int J Gynecol Cancer. 2020 Sep;30(9):1444-1449. doi: 10.1136/ijgc-2020-001528. Epub 2020 Jun 24. Int J Gynecol Cancer. 2020. PMID: 32586892

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

127 results

Search Page